参考文献/References:
[1].Santos-Martínez LE,Gómez-Tejada RA,Murillo-Jauregui CX,et al. [Chronic exposure to altitude. Clinical characteristics and diagnosis] [J]. Arch Cardiol Mex,2021,91(4):500-507.
[2].Luo Y,Yang X,Gao Y. Strategies for the prevention of acute mountain sickness and treatment for large groups making a rapid ascent in China[J]. Int J Cardiol,2013,169(2):97-100.
[3].Gudbjartsson T,Sigurdsson E,Gottfredsson M,et al. [High altitude illness and related diseases-a review] [J]. Laeknabladid,2019,105(11):499-507.
[4].Luks AM,Beidleman BA,Freer L,et al. Wilderness Medical Society Clinical Practice Guidelines for the Prevention,Diagnosis,and Treatment of Acute Altitude Illness:2024 Update[J]. Wilderness Environ Med,2024,35(1_suppl):2S-19S.
[5].Yaron M,Niermeyer S,Lindgren KN,et al. Evaluation of diagnostic criteria and incidence of acute mountain sickness in preverbal children [J]. Wilderness Environ Med,2002,13(1):21-26.
[6].Pradhan S,Yadav S,Neupane P,et al. Acute mountain sickness in children at 4380 meters in the Himalayas[J]. Wilderness Environ Med,2009,20(4):359-363.
[7].Theis MK,Honigman B,Yip R,et al. Acute mountain sickness in children at 2835 meters [J]. Am J Dis Child,1993,147(2):143-145.
[8].Dallimore J,Rowbotham EC. Incidence of acute mountain sickness in adolescents[J]. Wilderness Environ Med,2009,20(3):221-224.
[9].Moraga FA,Pedreros CP,Rodríguez CE. Acute mountain sickness in children and their parents after rapid ascent to 3500 m(Putre,Chile)[J]. Wilderness Environ Med,2008,19(4):287-292.
[10].Chan CW,Lin YC,Chiu YH,et al. Incidence and risk factors associated with acute mountain sickness in children trekking on Jade Mountain ,Taiwan[J]. J Travel Med,2016,23(1):tav008.
[11].Bloch J,Duplain H,Rimoldi SF,et al. Prevalence and time course of acute mountain sickness in older children and adolescents after rapid ascent to 3450 meters [J]. Pediatrics,2009,123(1):1-5.
[12].Rexhaj E,Garcin S,Rimoldi SF,et al. Reproducibility of acute mountain sickness in children and adults:a prospective study [J]. Pediatrics,2011,127(6):e1445-e1448.
[13].Ucrós S,Aparicio C,Castro-Rodriguez JA,et al. High altitude pulmonary edema in children:a systematic review [J]. Pediatr Pulmonol,2023,58(4):1059-1067.
[14].Rieger M,Algaze I,Rodriguez-Vasquez A,et al. Kids with altitude:acute mountain sickness and changes in body mass and total body water in children travelling to 3800 m[J]. Wilderness Environ Med,2022,33(1):33-42.
[15].Hurtado A,Escudero E,Pando J,et al. Cardiovascular and renal effects of chronic exposure to high altitude [J]. Nephrol Dial Transplant,2012,27(Suppl 4):iv11-iv16.
[16].Ostadal B,Kolar F. Cardiac adaptation to chronic high-altitude hypoxia:beneficial and adverse effects[J]. Respir Physiol Neurobiol,2007,158(2-3):224-236.
[17].Kriemler S,Radtke T,Bürgi F,et al. Short-term cardiorespiratory adaptation to high altitude in children compared with adults[J]. Scand J Med Sci Sports,2016,26(2):147-155.
[18].Lang M,Vizcaíno-Mu?oz G,Jopia P,et al. Physiological responses at rest and exercise to high altitude in lowland children and adolescents [J]. Life(Basel),2021,11(10):1009.
[19].Naeije R. Physiological adaptation of the cardiovascular system to high altitude[J]. Prog Cardiovasc Dis,2010,52(6):456-466.
[20].Yaron M,Niermeyer S,Lindgren KN,et al. Physiologic response to moderate altitude exposure among infants and young children[J]. High Alt Med Biol,2003,4(1):53-59.
[21].Garlick V,O’Connor A,Shubkin CD. High-altitude illness in the pediatric population:a review of the literature on prevention and treatment[J]. Curr Opin Pediatr,2017,29(4):503-509.
[22].Basnyat B,Gertsch JH,Holck PS,et al. Acetazolamide 125 mg BD is not significantly different from 375 mg BD in the prevention of acute mountain sickness:the prophylactic acetazolamide dosage comparison for efficacy (PACE) trial[J]. High Alt Med Biol,2006,7(1): 17-27.
[23].Scherrer U,Rexhaj E,Jayet PY,et al. New insights in the pathogenesis of high-altitude pulmonary edema [J]. Prog Cardiovasc Dis,2010,52(6):485-492.
[24].Asseri AA,Asiri ?A,Alwabel HH,et al. Severe acute reentry high altitude pulmonary edema in pediatric patients:report of three cases and literature review[J]. Turk J Pediatr,2022,64(2):400-407.
[25].Rimoldi SF,Rexhaj E,Duplain H,et al. Acute and chronic altitude-induced cognitive dysfunction in children and adolescents [J]. J Pediatr,2016,169:238-243.
[26].Chao CC,Chen LH,Lin YC,et al. Impact of a 3-day high-altitude trek on Xue Mountain (3886 m) ,Taiwan,on the emotional states of children:a prospective observational study[J]. High Alt Med Biol,2019,20(1):28-34.
[27].Cheng FY,Jeng MJ,Lin YC,et al. Incidence and severity of acute mountain sickness and associated symptoms in children trekking on Xue Mountain ,Taiwan[J]. PLoS One,2017,12(8):e0183207.
[28].Giesenhagen AM,Ivy DD,Brinton JT,et al. High altitude pulmonary edema in children:a single referral center evaluation [J].J Pediatr,2019,210:106-111.
[29].Southard A,Niermeyer S,Yaron M. Language used in Lake Louise Scoring System underestimates symptoms of acute mountain sickness in 4- to 11-year-old children[J]. High Alt Med Biol,2007,8(2):124-130.
[30].Eichstaedt CA,Mairb?url H,Song J,et al. Genetic predisposition to high-altitude pulmonary edema[J]. High Alt Med Biol,2020,21(1):28-36.
[31].Kelly TD,Meier M,Weinman JP,et al. High-altitude pulmonary edema in Colorado children:a cross-sectional survey and retrospective review [J]. High Alt Med Biol,2022,23(2):119-124.
[32].Coustet B,Lhuissier FJ,Vincent R,et al. Electrocardiographic changes during exercise in acute hypoxia and susceptibility to severe high-altitude illnesses[J]. Circulation,2015,131(9):786-794.
[33].Ramchandani R,Zhou Z,Parodi JB,et al. A systematic review of electrocardiographic changes in populations temporarily ascending to high altitudes[J]. Curr Probl Cardiol,2023,48(5):101630.
相似文献/References:
[1]刘颖,袁美锦.儿童与青少年心脏性猝死的病因和预防[J].心血管病学进展,2019,(6):935.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.024]
LIU Ying,YUAN Meijin.Causes and Prevention of Sudden Cardiac Death in Children and Adolescents[J].Advances in Cardiovascular Diseases,2019,(10):935.[doi:10.16806/j.cnki.issn.1004-3934.2019.06.024]
[2]罗芩 何庆.TNF凝集素样结构域：高原肺水肿药物治疗新选择罗芩 何庆2[J].心血管病学进展,2019,(9):1301.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.030]
LUO QinHE Qing.The Lectin-like Domain of TNF:New Drug Treatment Option for HAPE[J].Advances in Cardiovascular Diseases,2019,(10):1301.[doi:10.16806/j.cnki.issn.1004-3934.2019.00.030]
[3]马佳 陈肯 张宇清.儿童及青少年单纯收缩期高血压发病机制研究进展[J].心血管病学进展,2020,(4):392.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.016]
MA Jia,CHEN Ken,ZHANG Yuqing.The Pathogenesis of Isolated Systolic Hypertension in Children and Adolescents[J].Advances in Cardiovascular Diseases,2020,(10):392.[doi:10.16806/j.cnki.issn.1004-3934.2020.04.016]
[4]石树文 田雯.肠道微生物群与儿童川崎病[J].心血管病学进展,2020,(6):608.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.012]
SHI ShuwenTIAN Wen. Intestinal microbiota and children Kawasaki disease[J].Advances in Cardiovascular Diseases,2020,(10):608.[doi:10.16806/j.cnki.issn.1004-3934.2020.06.012]
[5]李祎 刘德敏.儿童对比剂肾病的研究进展[J].心血管病学进展,2021,(8):725.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.013]
LI Yi,LIU Demin.Contrast Induced Acute Kidney Injury In Children[J].Advances in Cardiovascular Diseases,2021,(10):725.[doi:10.16806/j.cnki.issn.1004-3934.2021.08.013]
[6]罗芩 何庆?/html>.腺苷2B受体激动剂对大鼠高原肺水肿的治疗作用[J].心血管病学进展,2021,(10):941.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.019]
LUO Qin,HE Qing.Therapeutic Effect of Adenosine 2B Receptor Agonist on High-Altitude Pulmonary Edema in Rats[J].Advances in Cardiovascular Diseases,2021,(10):941.[doi:10.16806/j.cnki.issn.1004-3934.2021.10.019]
[7]王蕊 赵鹏军.儿童肥厚型心肌病诊断方法及其对猝死风险评估的价值[J].心血管病学进展,2023,(8):681.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.003]
WANG Rui,ZHAO Pengjun.Diagnostic Methods of Hypertrophic Cardiomyopathy in Children and Its Value in Risk Assessment of Sudden Death[J].Advances in Cardiovascular Diseases,2023,(10):681.[doi:10.16806/j.cnki.issn.1004-3934.2023.08.003]
[8]李强强 顾虹.中国儿童肺动脉高压诊治现状[J].心血管病学进展,2024,(1):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]
LI Qiangqiang,GU Hong.Current Status of Diagnosis and Treatment of Pulmonary Hypertension in Chinese Children[J].Advances in Cardiovascular Diseases,2024,(10):7.[doi:10.16806/j.cnki.issn.1004-3934.2024.01.003]